Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
49.87 USD | +2.80% | +3.44% | -40.27% |
10:36pm | Cytokinetics Insider Sold Shares Worth $635,978, According to a Recent SEC Filing | MT |
May. 29 | Truist Securities Lowers Price Target on Cytokinetics to $70 From $86, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.27% | 5.57B | |
+15.55% | 118B | |
+12.66% | 106B | |
-2.53% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.92% | 15.56B | |
+6.19% | 13.63B | |
+28.83% | 12.27B |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- Earnings Flash (CYTK) CYTOKINETICS INCORPORATED Posts Q1 Revenue $835,000, vs. Street Est of $0.9M